Prot#ISIS 420915-CS5:Expanded Access Program for Inotersen (ISIS 420915) in Patients with Hereditary Transthyretin Amyloidosis (hATTR)

Project: Research project

StatusActive
Effective start/end date3/26/183/26/21

Funding

  • Clinigen Inc. (Prot#ISIS 420915- CS5)
  • Ionis Pharmaceuticals, Inc. (Prot#ISIS 420915- CS5)